Cancer Cell DNA Synthesis Inhibition

Inhibition of DNA synthesis in cancer cells is a therapeutic strategy that targets the fundamental process of DNA replication, which is essential for cell proliferation. By disrupting this process, these therapies aim to selectively impair the rapid division and survival of cancer cells, leading to cell cycle arrest and apoptosis. Many chemotherapeutic agents exploit this dependency by directly or indirectly inhibiting enzymes or pathways involved in DNA replication. Inhibiting DNA synthesis can induce replication stress, accumulation of DNA damage, activation of cell cycle checkpoints, and ultimately trigger cell death if the damage is irreparable.

Other names

Inhibition of DNA Replication in Cancer CellsDNA Replication Inhibition in CancerTargeting DNA Synthesis in Cancer Therapy

Disrupts DNA replication by targeting enzymes or pathways involved in DNA synthesis, leading to cell cycle arrest and apoptosis in cancer cells.